Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 013590/0676 | |
| Pages: | 3 |
| | Recorded: | 12/19/2002 | | |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
10176266
|
Filing Dt:
|
06/20/2002
|
|
Publication #:
|
|
Pub Dt:
|
07/03/2003
| | | | |
|
Title:
|
Transforming growth factor beta (TGF-beta) antagonist selectively neutralizes "pathological" TGF-beta
|
|
|
Assignee
|
|
|
|
|
| 6011 EXECUTIVE BOULEVARD, SUITE 325 |
| NATIONAL INSTITUTES OF HEALTH OFFICE OF TECHNOLOGY TRANSFER |
| ROCKVILLE, MARYLAND 20852 |
|
|
Correspondence name and address
|
| |
KLARQUIST SPARKMAN, LLP
|
| |
TANYA M. HARDING
|
| |
ONE WORLD TRADE CENTER, SUITE 1600
|
| |
121 S.W. SALMON STREET
|
| |
PORTLND, OR 97204-2988
|
Search Results as of:
04/28/2024 06:28 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
